Animal Vaccines Market

Global Animal Vaccines Market Outlook (2022-2032)

The global Animal Vaccines Market size was valued at US$ 12 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2022 to 2032.

Report Attributes	Details
Forecast Period	2022-2032
Historical Data Available for	2015-2021
Market Size Value in 2021	US$ 12 Billion
Project Market Forecast Value in 2032	US$ 29 Billion
Global Growth Rate (2022-2032)	9.2%
Market Share of North America	33%
Key Companies Profiled	Merck & Co. Inc. Zoetis Inc. Boehringer Ingelheim International GmbH Virbac Biogenesis Bago Indian Immunologicals Ltd. Elanco Animal Health Incorporated CEVA Animal Health (Pty) Ltd. Phibro Animal Health Corporation NEOGEN Corporation

An increase in the outbreak of disease amongst cattle along with canine disorders is boosting the sales of animal vaccines. Moreover, investment in research and development by government of different countries is positively influencing the demand for animal vaccines.

Demand Analysis of Animal Vaccines from 2015 to 2021 Vs Market Projections for 2022 to 2032

As per Fact.MR- a market research and competitive intelligence provider- from 2015 to 2021, global sales of animal vaccines flourished at a CAGR of 8.6%. By the end of the said historical period, the market reached a value of US$ 11 Billion. In the recent past, there have been numerous instances of outbreaks of various zoonotic diseases, both among animal as well as their transmission to humans. Hence, emphasis on animal vaccines has acquired major importance.

The current COVID-19 pandemic is also purported to be an end-product of zoonotic viral transmission. Given the fact that the novel coronavirus originated from bats, veterinarians are emphasizing on inoculating animal populations against the virus as well. This has significantly widened growth prospects for the industry during this crisis. Moreover, a recent outbreak of COVID in mink farms across Europe has also highlighted the need for introducing animal vaccines.

Manufacturers of animal vaccines are focusing on creating awareness regarding the importance of animal vaccination. As the food industry heavily relies on animals for milk and meat, the demand for vaccination is expected to grow. The market for animal vaccines is purported to grow 2.4x between 2022 and 2032.

What is driving the Global Market for Animal Vaccines?

Increasing Food Security Demand and Consequent Rise in Animal Husbandry boosting prospects

Increasing outbreaks of cattle disease and growing livestock population are the main reasons for the wide acceptance of animal vaccination globally. As animals serve as a vital source of meat, milk, protein, food, and other commercial products such as wool and leather, keeping a track of them has become essential. Most vaccines comprise of rabies, equine influenza virus and foot and mouth diseases vaccines. These vaccines help in preventing the transmission of infectious agents in animals.

Moreover, increase in concern for food security and increasing animal husbandry are escalating the demand for animal vaccines for the livestock population. In addition, demand for animal products for food and clothing has led to growth in livestock production globally. Furthermore, various factors such as variation in food preferences due to changing lifestyles and population growth are increasing the demand for livestock products. Technologically advanced vaccines and an increase in the outbreak of disorders are positively influencing the demand for animal vaccines.

Frequent Disease Outbreaks Bolstering Demand for Animal Vaccinations

Growing prevalence of zoonotic diseases have the potential to negatively impact human lives. Moreover, increasing population of both humans has given a rise to the transmission of pathogens within and between species. In addition, emerging and exotic animal diseases are a growing threat to human and animal health.

Improved demand for animal protein has resulted in increased commercial food animal production. Emerging zoonotic diseases of both companion and livestock animals are a major threat to public health. Furthermore, the possibility of world experiencing emerging disease outbreaks is high. Thus, the demand for vaccinating animals has increased.

Besides, there are several zoonotic diseases which have been transmitting to human beings, such as swine flu, bird flu and the current COVID-19 pandemic. In order to prevent this transmission, animal health specialists are emphasizing on the need to develop animal vaccines against a variety of infections.

Country-wise Analysis

How do Animal Vaccines Growth Prospects appear in North America?

Canine Disorders Driving Demand for Animal Vaccines in North America

The increasing presence of well-established pharmaceutical are striving for wide commercialization of their vaccines and propelling their geographical reach in countries like U.S. and Canada is expected to bolster the market growth. Moreover, high prevalence of livestock and zoonotic diseases leading to large-scale animal deaths is a major concern in the region.

In addition, the rising incidence of canine disorders along with a surge in the increasing adoption of vaccination is driving the demand for animal vaccines. Also, the rising pet population in the U.S. is a major factor contributing to the expansion of the regional market.Thus, North America is expected to hold more than 23% market share for animal vaccines.

How is the Asia Pacific Market Providing Opportunities for Animal Vaccines?

Increase in Livestock Population Influencing Demand for Animal Vaccines

Government initiatives and an increase in livestock population across India and China is expected to accelerate the growth of animal vaccines in Asia Pacific. Moreover, vegetarian lifestyle has increased the demand for milk and milk products. Thus, the cattle population in the country has increased. This, in turn, has increased the demand for vaccination in the region.

Furthermore, key players in the region are investing in research and development. Thus, Asia Pacific is expected to possess more than 20% market share for animal vaccines.

Category-Wise Insights

Which Animal Category is likely to Receive Maximum Boost?

Outbreak of Diseases in Livestock Augmenting Demand for Animal Vaccines

Rising livestock population is causing outbreak of diseases among cattle and sheep. Along with this, government initiatives are playing a key role in animal vaccination drives.

Increasing prevalence rate of E. coli in various cattle categories such as feedlot cattle, cattle on irrigated pasture, cattle at slaughter and cattle grazing rangeland forages is augmenting the demand for animal vaccines. Thus, by animal type, livestock is expected to hold more than 65% market share for animal vaccines.

Which Vaccine Type is expected to Accrue Maximum Market Gains?

Reduction in Mortality Rate Creating Lucrative Opportunities for Attenuated Live Vaccines

Live attenuation is not only the oldest vaccination method used in the veterinary field but now is also being used under trial for the development of additional applications. Some alternatives include the development of protein subunit vaccines for swine as they are given intramuscularly.

Thus, these products help in reducing the mortality rate by improving the life span of disease-affected swine. By product, attenuated live vaccines are expected to hold more than 30% market share for animal vaccines.

Competitive Landscape

Prominent manufacturers of animal vaccines are capitalizing on increasing government support across countries to promote animal health. This support is translating into the introduction of robust vaccine formulations against a wide variety of pathogen. Moreover, players are emphasizing on mergers, acquisitions and collaborations to secure firm footing in this highly competitive environment. Some notable developments are as follows:

• In August 2020, Merck & Co., Inc. completed the acquisition of IdentiGEN. The company is focusing on studying DNA of animals for livestock. Through this acquisition, Merck intends to provide complete transparency to food processors, producers and retailers, regarding animal traceability solutions to ensure that good quality food is available to consumers
• In January 2022, Zoetis Inc. announced that the U.S Food and Drug Administration has approved SolensiaTM (frunevetmab injection) to control the pain of osteoarthritis in cats, helping improve their mobility, comfort and overall well-being. The injection works by directly targeting the Nerve Growth Factor (NGF), a key OA pain driver

Key Segments Covered in the Animal Vaccines Industry Report

• By Product

  • Attenuated Live 
  • Recombinant
  • DNA 
  • Inactivated 
  • Subunit 

• By Animal Type

  • Livestock Animal Vaccines
    • Poultry
    • Ruminants
    • Swine
    • Aqua
  • Companion Animal Vaccines
    • Canine
    • Feline
    • Others

• By Route of Administration

  • Subcutaneous Administration 
  • Intranasal Administration 
  • Intramuscular Administration